Giga Solar Materials Corp. will add production lines at its photovoltaic conductive-paste plant in the Southern Taiwan Science Park to cope with booming orders from solar-energy equipment manufacturers. Industry executives pointed out ...
Sun Pharmaceutical Industries has received FDA approval for its abbreviated new drug application (ANDA) of Azelastine HCL nasal spray, 0.1% (137mcg/spray). The generic equivalent to Medpointe Pharm's Astelin nasal spray is indicated to ...
Tags: Sun Pharmaceutical Industries, Azelastine HCL nasal spray, Medicine
GeNO has received two new US patents for its proprietary nitric oxide(NO)generation and delivery technology. The US patent no.8,173,072 describes the conversion of nitrogen dioxide(NO2)to nitric oxide(NO),using the GeNO cartridge ...
Tags: nitric oxide(NO)generation, nitric oxide(NO)delivery, US Patents, GeNO
Mylan has reached a settlement in a patent litigation suit filed by Sunovion Pharmaceuticals concerning Mylan Specialty's abbreviated new drug application for Levalbuterol Hydrochloride (HCl) Inhalation Solution, 0.31mg/3 mL, 0.63mg/3 mL, ...
Tags: Sunovion Pharmaceuticals, Medicine
A 5 year $5.4m grant has been awarded to Profectus BioSciences and the Galveston National Laboratory (GNL) at the University of Texas Medical Branch at Galveston to support the development of a Vesicular Stomatitis virus-vectored vaccine ...
Tags: Trivalent Vaccine, rVSV-vectored filovirus, Ebola and Marburg Viruses
Regeneron Pharmaceuticals has received Japanese Ministry of Health,Labour and Welfare(MHLW)approval for its Eylea(aflibercept)injection to treat patients with neovascular age-related macular degeneration(wet AMD)symptoms. Regeneron chief ...
Tags: Regeneron Pharmaceuticals, Eylea Injection, wet AMD, George Yancopoulos
Clinical stage biopharmaceutical company, Tocagen, has entered into a partnership agreement with MRI Interventions and Brainlab. Under the collaboration, Tocagen will use MRI Interventions' ClearPoint neuro intervention system at selected ...
Pulmatrix has announced the results of a clinical study showing that an iCALM (inhaled cationic airway lining modulator therapy) attenuated allergen-induced bronchitis in susceptible asthmatic patients. The study concluded that iCALM is a ...
Jennerex has treated the first patient in a Phase 2 clinical trial of intravenous treatment with JX-594 for patients with advanced hepatocellular carcinoma(HCC)who have not received treatment with sorafeni. The ...
Tags: hepatocellular carcinoma, JX-594, intravenous treatment, Jennerex
Sweden-A former brewery may not seem the obvious choice for a live venue,but that is exactly the use that Stockholm's Bryggarsalen has been put to.A newly-installed Alcons Audio system ensures that the sound for live events has a crisp head ...
Tags: Audio system, professional audio systems, Alcons systems
Author(s): Miriam Berg Author(s): Lindsey O'Hern The Alliance’s Washington, D.C., LEED-CI Silver headquarters already is energy-efficient – but it recently became even more so with a new lighting upgrade! The first phase of ...
Tags: ALA, architectural lighting design, Philips Lightolieris
The USFDA has approved ThromboGenics'Jetrea(ocriplasmin)for the treatment of symptomatic vitreomacular adhesion(VMA). The approval was based on the Phase III trial data which demonstrated that Jetrea is superior to placebo for the ...
Tags: ThromboGenics'Jetrea, symptomatic vitreomacular adhesion, USFDA
The unabated volatility in gold price has forced India's middle-class consumers to try out a cheaper option and their obvious choice now is to opt for silver jewellery.After an initial poor performance,last monsoon season in India improved ...
Tags: gold, silver jewellery, silver, investment
USA - GLP's groundbreaking impression Spot One is among several of the German lighting manufacturer's LED fixtures that are presently dominating high profile touring productions in the US. However, while the impression series has extended ...
Tags: LED fixtures, German lighting manufacturer, innovative technology
Swedish automotive safety systems manufacturer Autoliv is planning to invest about $13m to build a new processing facility at its Utah facility in the US. Built to meet demand for airbag gas generant, the new facility in Promontory is ...
Tags: Autoliv, New Processing Facility, Utah